C12N 2760/20133
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2760/20133 (Use of viral protein as therapeutic agent other than vaccine) appears on 4 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 5
- Assignees
- 6
- Inventors
- 7
- Latest grant
- 3 Nov 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 1 |
| 2020 | 2 | 0 |
| 2021 | 0 | 1 |
By publication year.
Recent patents
- Chimeric VSV virus compositions and methods of use thereof for treatment of cancer3 Nov 2020US 10,821,143 B2Yale University
- RVG Derived peptides4 Feb 2020US 10,548,984 B2United Arab Emirates University
- Chimeric VSV virus compositions and methods of use thereof for treatment of cancer15 Jan 2019US 10,179,154 B2Yale University
- Products useful for the treatment of malignant neoplasms of the human nervous system12 Jan 2016US 9,234,005 B2Centre National De La Recherche Scientifique
- Chimeric vsv virus compositions and methods of use thereof for treatment of cancer3 Jun 2021US 2021/0161979 A1Yale University
- Chimeric vsv virus compositions and methods of use thereof for treatment of cancer25 Apr 2019US 2019/0117711 A1Yale University
- Rvg derived peptides1 Feb 2018US 2018/0028675 A1United Arab Emirates University
- Chimeric vsv virus compositions and methods of use thereof for treatment of cancer13 Oct 2016US 2016/0296572 A1Yale University
- Products useful for the treatment of malignant neoplasms of the human nervous system9 Oct 2014US 2014/0302123 A1Centre National De La Recherche Scientifique
Most cited
By later US patents